National Hospitalization Trends for Pediatric Pneumonia and Associated Complications
Top Cited Papers
- 1 August 2010
- journal article
- Published by American Academy of Pediatrics (AAP)
- Vol. 126 (2), 204-213
- https://doi.org/10.1542/peds.2009-3109
Abstract
OBJECTIVE: To determine current rates of and trends in hospitalizations for community-acquired pneumonia (CAP) and CAP-associated complications among children. METHODS: We performed a cross-sectional, retrospective, cohort study by using the 1997, 2000, 2003, and 2006 Kids' Inpatient Database. National estimates for CAP and CAP-associated local and systemic complication rates were calculated for children ≤18 years of age. Patients with comorbid conditions or in-hospital birth status were excluded. Percentage changes were calculated by using 1997 (before heptavalent pneumococcal conjugate vaccine [PCV7]) and 2006 (after PCV7) data. RESULTS: There were a total of 619 102 CAP discharges for 1997, 2000, 2003, and 2006, after application of inclusion and exclusion criteria. Overall rates of CAP discharges did not change substantially between 1997 and 2006, but stratification according to age revealed a 22% decrease for children <1 year of age, minimal change for children 1 to 5 years of age, and increases for children 6 to 12 years (22%) and ≥13 years (41%) of age. Systemic complication rates were highest among children <1 year of age but decreased by 36%. In all other age groups, systemic complication rates remained stable. Local complication rates increased 78% overall. Children 1 to 5 years of age had the highest local complication rates. CONCLUSIONS: After the introduction of PCV7 in 2000, rates of CAP-associated systemic complications decreased only for children <1 year of age. Rates of pediatric CAP-associated local complications are increasing in all age groups.Keywords
This publication has 42 references indexed in Scilit:
- Prevalence of Occult Bacteremia in Children Aged 3 to 36 Months Presenting to the Emergency Department with Fever in the Postpneumococcal Conjugate Vaccine EraAcademic Emergency Medicine, 2009
- FIVE-FOLD INCREASE IN PEDIATRIC PARAPNEUMONIC EMPYEMA SINCE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINEThe Pediatric Infectious Disease Journal, 2008
- Pediatric Parapneumonic Empyema, SpainEmerging Infectious Diseases, 2008
- Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United StatesClinical Infectious Diseases, 2008
- Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Antimicrobial Resistance of Invasive Streptococcus pneumoniae Isolates in Dallas, TX, Children From 1999 Through 2005The Pediatric Infectious Disease Journal, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of BacteremiaClinical Infectious Diseases, 2006
- Trends in Invasive Pneumococcal Disease—Associated HospitalizationsClinical Infectious Diseases, 2006
- Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001The Pediatric Infectious Disease Journal, 2003
- Pathogenesis of Pneumococcal InfectionNew England Journal of Medicine, 1995